Asociación entre la adherencia terapéutica y las fases de duelo en pacientes con diabetes mellitus tipo 2

Pub Date : 2024-02-01 DOI:10.1016/j.semerg.2023.102178
A. Medina Ávila , R. Leyva Jiménez
{"title":"Asociación entre la adherencia terapéutica y las fases de duelo en pacientes con diabetes mellitus tipo 2","authors":"A. Medina Ávila ,&nbsp;R. Leyva Jiménez","doi":"10.1016/j.semerg.2023.102178","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the association between therapeutic adherence and the phases of grief in patients with type 2 diabetes mellitus.</p></div><div><h3>Design</h3><p>Cross-sectional observational study.</p></div><div><h3>Site</h3><p>Family Medicine Unit No. 53 of the Mexican Institute of Social Security in the State of Guanajuato.</p></div><div><h3>Participants</h3><p>A total of 354 patients with type 2 diabetes mellitus were recruited, of whom 236 corresponded to the group without therapeutic adherence and 118 to the group with therapeutic adherence.</p></div><div><h3>Interventions</h3><p>Two structured surveys were administered to both groups.</p></div><div><h3>Main measurements</h3><p>The Morisky 8 scale was used to measure therapeutic adherence and the phases of grief scale (EFD-66) to measure grief due to loss of health.</p></div><div><h3>Results</h3><p>The median denial phase and depression phase scores were higher in the nonadherence group than in the adherence group (<em>p</em> <!-->=<!--> <!-->.000). The median negotiation phase and acceptance phase score was higher in the adherence group than in the nonadherence group (<em>p</em> <!-->=<!--> <!-->.000). Multivariate analysis identifies that denial is the main factor associated with non-adherence (OR<!--> <!-->=<!--> <!-->1.25; 95% CI: 1.14–1.37); while negotiation (OR<!--> <!-->=<!--> <!-->0.88; 95% CI: 0.82–0.94) and acceptance are associated with adherence (OR<!--> <!-->=<!--> <!-->0.79; 95% CI: 0.75–0.83).</p></div><div><h3>Conclusions</h3><p>There is an association between therapeutic adherence and phases of grief.</p></div>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1138359323002587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To evaluate the association between therapeutic adherence and the phases of grief in patients with type 2 diabetes mellitus.

Design

Cross-sectional observational study.

Site

Family Medicine Unit No. 53 of the Mexican Institute of Social Security in the State of Guanajuato.

Participants

A total of 354 patients with type 2 diabetes mellitus were recruited, of whom 236 corresponded to the group without therapeutic adherence and 118 to the group with therapeutic adherence.

Interventions

Two structured surveys were administered to both groups.

Main measurements

The Morisky 8 scale was used to measure therapeutic adherence and the phases of grief scale (EFD-66) to measure grief due to loss of health.

Results

The median denial phase and depression phase scores were higher in the nonadherence group than in the adherence group (p = .000). The median negotiation phase and acceptance phase score was higher in the adherence group than in the nonadherence group (p = .000). Multivariate analysis identifies that denial is the main factor associated with non-adherence (OR = 1.25; 95% CI: 1.14–1.37); while negotiation (OR = 0.88; 95% CI: 0.82–0.94) and acceptance are associated with adherence (OR = 0.79; 95% CI: 0.75–0.83).

Conclusions

There is an association between therapeutic adherence and phases of grief.

分享
查看原文
[2型糖尿病患者坚持治疗与悲痛阶段之间的关系]。
目的评估 2 型糖尿病患者的治疗依从性与悲伤阶段之间的关联:横断面观察研究。研究地点地点:瓜纳华托州墨西哥社会保障局第53家庭医学科:共招募了 354 名 2 型糖尿病患者,其中 236 人属于未坚持治疗组,118 人属于坚持治疗组:主要测量指标:莫里斯基8量表用于测量治疗依从性,悲伤阶段量表(EFD-66)用于测量因失去健康而产生的悲伤:不坚持治疗组的否认阶段和抑郁阶段得分中位数高于坚持治疗组(P=.000)。坚持治疗组的协商阶段和接受阶段得分中位数高于未坚持治疗组(P=.000)。多变量分析表明,否认是与不坚持治疗相关的主要因素(OR=1.25;95% CI:1.14-1.37);而协商(OR=0.88;95% CI:0.82-0.94)和接受与坚持治疗相关(OR=0.79;95% CI:0.75-0.83):结论:坚持治疗与悲伤阶段之间存在关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信